For cat lovers and veterinary professionals in the United States, there’s exciting news regarding feline infectious peritonitis (FIP) treatment. Stokes Pharmacy, in partnership with the Bova Group, has announced the availability of a compounded oral formulation of GS-441524, a groundbreaking medication for Fip Cats Treatment. This oral treatment became accessible on June 1st, 2024, offering a significant advancement in combating this once-devastating disease.
Feline infectious peritonitis had long been considered an almost invariably fatal illness. However, the development of GS-441524 in 2018 marked a turning point. This unique antiviral compound has demonstrated remarkable efficacy and safety in treating FIP in cats. Clinical trials, primarily conducted in Australia and the UK, have consistently shown positive outcomes, bringing hope where there was once despair for fip cats treatment.
Previously, GS-441524 was not FDA-approved, leading many desperate cat owners in the U.S. to seek treatment through unregulated and often unreliable black market sources. The recent announcement from Stokes Pharmacy and Bova Group, coupled with the FDA Center for Veterinary Medicine (CVM) acknowledging compounded GS-441524 under Guidance for Industry #256, provides a legal and reliable pathway for fip cats treatment in the US. Veterinarians are now informed that prescribing compounded GS-441524 is permissible, offering a significant ray of hope in the fight against this feline disease.
Initially administered as an injection, the shift to an oral formulation of GS-441524 is a crucial step forward. Oral administration makes fip cats treatment more practical and less stressful for both cats and their owners. This user-friendly approach broadens the accessibility of this life-saving medication, integrating seamlessly into home care routines.
To obtain GS-441524 for fip cats treatment, a veterinary prescription is necessary. If your cat has been diagnosed with FIP or you suspect they may have the condition, it is essential to consult with your veterinarian. They can provide guidance on diagnosis, discuss if GS-441524 treatment is appropriate for your cat, and explain how to obtain this innovative therapy. This development signifies a major leap forward in feline health and offers renewed hope for effective fip cats treatment in the United States.
Find out more about this exciting news here
Cornell Feline Health Center Webinar: Feline Infectious Peritonitis (FIP) treatment in the USA
